Increased respiratory symptoms following surgery in children exposed to environmental tobacco smoke

Drongowski, Robert A.; Lee, Donald; Reynolds, Paul I.; Malviya, Shobha; Harmon, Carroll M.; Geiger, James D.; Lelli, Joseph L.; Coran, Arnold G.

doi:10.1046/j.1460-9592.2003.01100.x

Cited by 31 publications

(29 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Siendo que la edad promedio de experimentación con el tabaco en esta población resultó ser de 12 años, los programas de prevención deberían iniciarse durante el segundo ciclo de educación general básica, es decir, antes de la edad de inicio, entre los 9 y 10 años de edad. El micro ambiente donde crece el niño -el contexto social familiar -ejerce fuerte presión en el desarrollo o no de factores protectores que influencian el modo de vida saludable [19][20][21][22] .…”

Section: Discussionunclassified

Tabaquismo durante la adolescencia temprana: estudio en escolares argentinos

Bolzán¹,

Peleteiro²

2003

J. Pediatr. (Rio J.)

View full text Add to dashboard Cite

Section: Discussionunclassified

Tabaquismo durante la adolescencia temprana: estudio en escolares argentinos

Bolzán¹,

Peleteiro²

2003

J. Pediatr. (Rio J.)

View full text Add to dashboard Cite

“…• respiratory complications associated with anesthesia [195][196][197][198][199] • Infections, including…”

Section: Effects On the Child Of Shs Exposurementioning

confidence: 99%

Secondhand and Prenatal Tobacco Smoke Exposure

Best¹

2009

Pediatrics

View full text Add to dashboard Cite

Secondhand tobacco smoke (SHS) exposure of children and their families causes significant morbidity and mortality. In their personal and professional roles, pediatricians have many opportunities to advocate for elimination of SHS exposure of children, to counsel tobacco users to quit, and to counsel children never to start. This report discusses the harms of tobacco use and SHS exposure, the extent and costs of tobacco use and SHS exposure, and the evidence that supports counseling and other clinical interventions in the cycle of tobacco use. Recommendations for future research, policy, and clinical practice change are discussed. To improve understanding and provide support for these activities, the harms of SHS exposure are discussed, effective ways to eliminate or reduce SHS exposure are presented, and policies that support a smoke-free environment are outlined.

show abstract

“…Various compounds in tobacco formulations increase blood pressure, heart rate (HR), and systemic vascular resistance, whereas by-products interfere with oxygen uptake, transport, and end-organ delivery [2]. The risk of intraoperative cardiovascular as well as pulmonary complications is two to 5 times greater in smokers than in the general population [2,16,17]. This constellation of medical problems arises in part from the inflammatory reaction that adds to the aging of arteries and inhibits immune function [2,18,19].…”

Section: Smoking and Anesthesiamentioning

confidence: 99%